You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. SanFlow: A Therapeutic Agent for Use in the Field for Traumatic Brain Injury

    SBC: ANTIRADICAL THERAPEUTICS LLC            Topic: DHA17011

    An ideal therapeutic for traumatic brain injury (TBI) accompanied by hemorrhagic shock (HS) should serve both as a resuscitation fluid to restore perfusion pressure while directly protecting the brain from secondary injury. Previous work in mice demonstra

    SBIR Phase II 2019 Department of DefenseDefense Health Agency
  2. Integrated system for field, clinic and laboratory preparation of biological specimens for microscopy

    SBC: Microscopy Innovations, LLC            Topic: DHP16C004

    Biological tissues collection is problematic and risky even under ideal conditions; when collection occurs in remote locations, or by minimally- trained personnel, as may occur in response to an emerging disease threat, risks are magnified. This proposal addresses this issue by developing a Field Fixation Unit (FFU) for specimen collection that utilizes single-use capsules pre-loaded with fixative ...

    STTR Phase II 2018 Department of DefenseDefense Health Agency
  3. SanFlow: A Therapeutic Agent for Use in the Field for Traumatic Brain Injury

    SBC: ANTIRADICAL THERAPEUTICS LLC            Topic: DHA17011

    We hypothesize that the use of SanFlow (aka polynitroxylated pegylated hemoglobin; PNPH) will ultimately translate to the reduction of mortality and morbidity, including post-traumatic stress disorder, from battle field traumatic brain injury (TBI). Towards that end, the present SBIR Phase 1 proposal will provide safety and efficacy results of SanFlow in a new guinea pig model of traumatic brain i ...

    SBIR Phase I 2017 Department of DefenseDefense Health Agency
  4. Field, clinic and lab preparation of emerging pathogens and other biological specimens for microscopy

    SBC: Microscopy Innovations, LLC            Topic: DHP16C004

    Biological tissues collection is problematic and risky even under ideal conditions: when collection occurs in remote locations, or by minimally-trained personnel, as may occur in response to an emerging disease threat, risks are magnified. This proposal addresses this issue by developing a Field Fixation Unit (FFU) for specimen collection that utilizes single-use capsules pre-loaded with fixative. ...

    STTR Phase I 2017 Department of DefenseDefense Health Agency
  5. Skin Substitute Technology for Chimeric Autologous/Allogeneic Constructs for Skin Regeneration- Preclinical Studies

    SBC: Stratatech Corporation            Topic: OSD11H10

    Complex skin defects, including burns and trauma, represent a major medical problem affecting both military and civilian populations. In recent military engagements, burns account for approximately 5% of combat casualties. Furthermore, approximately 1.25 million Americans each year require medical attention for complex skin defects, with 50,000 people hospitalized for burns and 13,000 requiring sk ...

    SBIR Phase II 2015 Department of DefenseDefense Health Agency
  6. Chimeric Autologous/Allogeneic Constructs for Skin Regeneration

    SBC: Stratatech Corporation            Topic: OSD11H10

    Complex skin defects, including burns and trauma, represent a major medical problem affecting both military and civilian populations. In recent military engagements, burns account for approximately 5% of combat casualties. Furthermore, approximately 1.25 million Americans each year require medical attention for complex skin defects, with 50,000 people hospitalized for burns and 13,000 requiring sk ...

    SBIR Phase II 2013 Department of DefenseDefense Health Agency
  7. Chimeric Autologous/Allogeneic Constructs for Skin Regeneration

    SBC: Stratatech Corporation            Topic: OSD11H10

    Complex skin defects, including burns and trauma, represent a major medical problem affecting both military and civilian populations. In recent military engagements, burns account for approximately 5% of combat casualties. Furthermore, approximately 1.25 million Americans each year require medical attention for complex skin defects, with 50,000 people hospitalized for burns and 13,000 requiring sk ...

    SBIR Phase I 2012 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government